Treatment for portal hypertension in patients with cirrhosis is based on the use of β-blockers with or without organic nitrates; however, these agents are effective in less than 50% of patients ...

is an important cause of bleeding in patients with cirrhosis associated with portal hypertension. Histologically, the condition is characterized by dilation of the mucosal and submucosal vessels ...

These animals develop cirrhosis, portal hypertension, and HPS at 4–5 weeks after surgery. Most other animal models of cirrhosis, such as that induced by carbon tetrachloride, have not proved ...

Causes of portal hypertension can be prehepatic (such as portal vein thrombosis), hepatic (commonly liver cirrhosis and hepatic fibrosis) or posthepatic (such as hepatic vein obstruction).

Portal hypertension is responsible for the major complications of cirrhosis such as ... and intra-abdominal surgery (e.g., ...